Dr. Consolata Uzzi, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 174 Hillside Ave, Newark, NJ 07108 Phone: 201-667-4000 |
Dr. Paraclet Louissaint, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 669 Elizabeth Ave, Newark, NJ 07112 Phone: 973-923-6452 Fax: 973-923-1979 |
Katie Marie Sanghvi, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 150 Bergen St., The University Hospital, Newark, NJ 07103 Phone: 973-972-4300 Fax: 513-831-5985 |
Dr. Sheila R Rugnao, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 185 S Orange Ave # G506, Newark, NJ 07103 Phone: 415-624-5306 |
Dr. Cynthia Darlene Santos, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 150 Bergen St, Newark, NJ 07103 Phone: 973-972-9438 |
Scarlett Finocchiaro, General Practice Medicare: Not Enrolled in Medicare Practice Location: 201 Lyons Ave, Newark, NJ 07112 Phone: 973-926-7000 |
News Archive
PLC Systems Inc., a company focused on innovative cardiac and vascular medical device-based technologies, today reported financial results for the three and nine month periods ended September 30, 2009.
AbbVie today announced its investigational medicine venetoclax, an inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, has been granted Breakthrough Therapy Designation by the FDA for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.
Lary C. Walker, PhD, research professor of neuropharmacology and neurologic diseases and associate professor of neurology, Yerkes National Primate Research Center, Emory University, is a recipient of the 2014 MetLife Foundation Awards for Medical Research. The winners were recognized at a scientific briefing and awards ceremony today in New York.
Taking certain cancer-fighting drugs while undergoing radiation therapy may not increase survival for patients, but may, instead, increase side effects, according to a team of researchers. The drugs, however, may be beneficial for patients who are not undergoing radiation therapy.
Consuming two or more drinks per day could increase a person's risk of pancreatic cancer by about 22 percent, according to data published in Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
› Verified 6 days ago